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Renal mechanisms of genetic hypertension: From the molecular level to
the intact organism. Human primary hypertension is a polygenic disease;
its phenotypic expression is modulated by the environment. Though the
kidney can play a major role in the initiation and maintainance of
hypertension, many questions remain open. Kidney cross-transplantation
demonstrated that hypertension can be transplanted with the kidney in all
strains of genetically hypertensive rats where such experiments have been
carried out. Data consistent with those in rats were also obtained in
humans. Many abnormalities in kidney function and ion transport were
described in hypertensive rats and humans, but the logical sequence from
genetic-molecular to cellular abnormality that causes hypertension via
modification of kidney function is difficult to prove. We established this
sequence in Milan hypertensive rats using a variety of experimental
techniques (isolated kidney and renal cell function, cell membrane ion
transport, cross-immunization with membrane proteins, molecular biol-
ogy, genetic crosses and manipulation). Such studies led to the identifica-
tion of a polymorphism in the cytoskeletal protein adducin. This polymor-
phism seems involved in blood pressure regulation both in rats and
humans. Preliminary results suggest that adducin polymorphism affects
kidney function by modulating the overall capacity of tubular epithelial
cells to transport ions modifying the assembly of actin cytoskeleton.
Human primary hypertension has a heterogeneous nature. A
variety of polygenic and environmental factors produce the same
final phenotype of increased blood pressure with increased pe-
ripheral resistance. The difficulty of understanding the genetic
mechanisms of hypertension is even greater when one attempts to
study the nature of possible genetic renal mechanisms that lead to
primary hypertension. In fact, the phenotypic expressions of
postulated genetic renal mechanisms will be modulated by the
reciprocal relationships between renal function and blood pres-
sure themselves, via renal perfusion pressure, or the mechanisms
that control body fluid volumes and electrolyte content (with all
their regulatory hormones), the sympathetic nervous system and
so on. For these reasons it is practically impossible to say whether
any observed kidney abnormality arises from a primary renal
alteration or some extrarenal factor. The common observation of
normal renal function in recent onset benign primary hyperten-
sion, in spite of elevated renal perfusion pressure, suggests that in
this case the pressure natriuresis curve also works less efficiently
(that is, with a rightward shift), indicating that the kidney with
apparently normal function is nevertheless elevating blood pres-
sure [1, 2]. One approach to solve this intriguing problem has been
the study of individuals who were still in the normotensive stage,
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but had a high probability of developing hypertension [3]. Though
such studies gave contrasting results, they clearly indicated that
some renal function abnormality was present in all cases before
the development of hypertension, and that hypertension may be
part of the response that can be expected from the renal abnor-
mality.
Due to the tremendous complexity of the pathogenesis of
primary hypertension in humans, the rat models of genetic hyper-
tension may help to detect and understand some genetic mecha-
nisms at work, provided that the rat model shares some patho-
physiological similarities with the human disease. It is conceivable
that each animal model will be particularly informative for only a
subset of hypertensive patients who share common pathogenetic
mechanisms with the model. The identification of such subsets of
hypertensive patients depends on our ability to identify those
specific functions that are directly affected by the primary genetic
mechanism in spite of the complexities of the physiological
interrelationships in the whole body.
Accordingly, the aim is to identify those intermediate pheno-
types that display some form of Mendelian inheritance, and help
to explain some specific renal pathophysiological findings in
hypertension. When such intermediate phenotypes are detected,
the next step is the identification of some as yet unknown
abnormal proteins or candidate genes responsible for the inter-
mediate phenotype. Since it is clear that blood pressure is under
polygenic control, surely more than one intermediate phenotype
will be identified. Space limitation does not allow an exhaustive
analysis of all findings in all rat strains. We therefore limit our
discussion to the dissection of the "hypertension" phenotype in
Milano hypertensive strain (MHS) rats, focusing on similarities
and differences with other genetic rat models, to provide a
paradigm to the way we believe the rat model should be used to
understand human hypertension.
This review summarizes the following: (1) kidney transplanta-
tion experiments that provided the major and more consistent
evidence of the kidney's major causal role in the pathogenesis of
rat genetic hypertension. The few data available from humans are
also included. (2) The dissection of the final (whole-body) com-
plex phenotypes "renal pressor mechanism" and "hypertension"
into intermediate phenotypes (cellular and biochemico-molecular
mechanisms) is discussed, as is (3) the elucidation of the DNA
polymorphism underlying one such genetic-biochemical mecha-
nism, and its possible relationships with the intermediate pheno-
types and hypertension.
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Kidney transplantation experiments
The most straightforward experiment for the evaluation of a
primary pressor role of the kidney is cross-transplantation be-
tween genetic hypertensive rats and their appropriate controls.
Since secondary kidney modifications caused by hypertension
interfere with the interpretation of the results, transplantation was
also performed at the prehypertensive stage or between animals
whose blood pressure has been kept normal with antihypertensive
treatment. The experimental protocol was essentially the same for
all rat strains consisting in the removal of both recipient's kidneys
and the transplantation of only one kidney from the donor.
Kidney cross-transplantation experiments have been performed
either in adult (when hypertension was fully developed) [4] and in
young animals (at the development of hypertension) [5]. In either
case the kidney from MHS rats (the hypertensive strain) caused
higher blood pressure in the recipient than the kidney of MNS
(the normotensive strain) rats. Furthermore, the blood pressure
of an adult MHS hypertensive rat was reduced after removal of
native kidneys and grafting of an adult MNS kidney.
Similar results were obtained in spontaneously hypertensive
rats (SHR) [6—9] and DahI [10—12] strains. In either case, however,
it was possible to demonstrate that besides the primary renal
mechanism, some other extrarenal mechanisms contributed to the
blood pressure difference between the hypertensive strain and its
control.
To support the experiments performed in rats, the effect of
renal transplantation on hypertension of the recipient was also
looked for in humans. For obvious reasons, human studies have
the limitations of any retrospective study. Guidi et al followed up
50 patients for two years after cadaver renal transplant from
unrelated donors [13]. The authors measured the blood pressure
of the parents of all donors and recipients (the actual blood
pressure of donors and recipients was obviously unreliable, since
the recipient was on chronic hemodialysis and the donor was in
deep coma due to trauma or cerebral hemorrhage), and divided
the donors and recipients according to their family history of
hypertension. They found that the recipients of a kidney from a
normotensive family had lower blood pressure and needed less
antihypertensive treatment than the recipients of a kidney from a
hypertensive family [13]. Recently, the authors extended their
analysis to 85 patients followed up for eight years and obtained
the same results (Note added in proof). A similar type of analysis
was done by Strandgaard and Hansen [14]. They observed that the
recipients of kidneys from cadaver donors who died of head injury
or cerebral tumor had lower blood pressure and required less
antihypertensive therapy than the recipients of kidneys coming
from donors who died of cerebral hemorrhage (possibly linked to
pre-existing hypertension). Curtis et al reported the complete
normalization of blood pressure after kidney transplantation in six
black subjects whose renal failure was due to nephrosclerosis from
primary hypertension [15].
Dissection of the phenotype
Data presented so far clearly indicate that the kidney plays a
major role in the development of hypertension. However, the
nature of the physiological and biochemical defect is unclear.
Many biochemical-physiological studies were then performed in
the different rat strains.
Kidney function measurements
The studies on whole animals may be summarized as follows:
GFR and urinary flow are higher while plasma and renal renin are
lower in young prehypertensive MHS than in MNS of the same
age. These differences tend to disappear as hypertension fully
develops in MHS. Balance studies showed a renal Na retention in
MHS during the development of hypertension [16].
Isolated perfused kidneys from young prehypertensive (4 weeks
old) MHS rats have increased glomerular filtration rate (GFR),
urinary flow, overall tubular sodium reabsorption and kidney 02
consumption, and lower vascular resistance than isolated perfused
kidneys from normotensive rats of the same age [17, 18]. The
pressure-natriuresis curves are similar in prehypertensive MHS
and MNS, but due to the higher GFR, the tubular Na load is much
higher in MHS. Kidneys removed from adult animals showed
almost the same functional differences [19]. These results suggest
that a primary increase of tubular reabsorption in MHS may be
responsible for both renal functional changes and the greater
pressor effect after kidney transplantation. To gain further infor-
mation about the mechanisms underlying tubular reabsorption in
MHS rats, the effects of the diuretic bumetanide, a selective
inhibitor of Na-K-Cl cotransport in the thick ascending limb of
Henle's loop, was tested on the same isolated kidneys removed
from young MHS and MNS rats [201. The tubular effect of
bumetanide in MHS kidneys was much greater and appeared at a
lower concentration than that in MNS kidneys. Also, the natri-
uretic effect of ouabain (10 M) was much greater in MHS than
in MNS isolated kidney [21], though the difference appeared only
in later experimental times. It was likely that perfusion in vitro of
isolated MHS kidneys removed some factor(s) that prevented the
full tubular action of ouabain. Consistent with this conclusion,
high levels of circulating ouabain-like factors were found in MHS
[22, 23].
Data on DahI rat strain (DS) are somehow more difficult to
interpret since some abnormalities of kidney function may be
induced by the high sodium diet. Whatever the case, DS rats have
several glomerular morphologic abnormalities (mesangial widen-
ing, arteriolar myo-intimal cell hyperplasia, and interstitial fibro-
sis) also prior to the high sodium diet, which may per se reduce
GFR [24]. On low and high sodium diets DS rats have lower GFR
and fractional sodium excretion (FENa), higher renal vascular
resistance, and rightward shift of the pressure-natriuresis curve
compared to the control strain whose blood pressure does not
increase with high sodium diet (DR) [25—27]. Overall these
findings demonstrate an impairment of the DS kidney's ability to
excrete sodium. This intrinsic renal defect triggers the release of
the ouabain-like factor [28]. In summary, the most clear-cut
abnormalities in DS kidney are: (1) a reduction of the overall
glomerular filtration rate partly secondary to the glomerular
morphological abnormalities; and (2) a decrease in fractional Na
excretion and rightward shift of the pressure-natriuresis curve.
When SHR are only moderately hypertensive (6 weeks old),
they have reduced GFR, RBF and increased renal vascular
resistance [29]. At 12 to 14 weeks of age when hypertension is fully
developed, GFR and RBF become normal [30—32]. The reduction
of GFR in young animals seems to be due to enhanced tubulo-
glomerular feedback, reduced ultrafiltration coefficient and gb-
merular plasma flow [31]. The vascular reactivity to angiotensin II
is enhanced [33] as well as the tone of preglomerular vessels [34]
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and medullary vascular resistance [351 Exaggerated salt and water
renal retention occurs during the development of hypertension
[36—38]. Isolated perfused adult SHR kidneys have reduced RPF,
GFR, total urinary sodium excretion and proximal FENa [1 1t
vitro experiments confirm these findings: proximal tubules of SHR
have increased activity of the sodium pump [40] and Na-H
exchange [41], the factors mainly responsible for sodium reab-
sorption in this segment of the nephron. In conclusion, the most
likely intrarenal major cause responsible for the pressor effect of
the kidney after transplantation is increased tone of the preglo-
merular vessels associated with a primary increase in proximal
tubular reabsorption of Na. The enhanced renal vascular tone in
SHR is certainly influenced by the sympathetic drive to the kidney
[42].
Several problems may arise in comparisons of different strains
of rats because of: (1) differences in the methods and experimen-
tal conditions used for measuring renal function; (2) difficulties in
dissecting primary from secondary kidney function changes and in
selecting those experimental results which better reflect the
function of the kidney in its body environment; and (3) genetic
heterogeneity of some hypertensive rat strains. However, some
general statements can be made. Two major functional patterns
have been found. In DS and SHR rats renal vascular resistance
are increased and GFR tends to be lower, while in MHS rats the
opposite changes occur. The cell types whose alterations are
responsible for the renal dysfunction seem to be vascular smooth
muscle or glomerular cells in DS and SHR, and tubular cell in
MHS. Neural cells, particularly sympathetic nerve endings, should
also be considered in the cases of DS and SHR. It is interesting to
note that two different patterns of renal function have been found
in offspring of hypertensive patients. In an Italian sample, Bianchi
et al found that GFR and RBF were faster and renin was lower in
a group of offspring of hypertensive parents, when they were
compared to similar offspring of normotensive parents [43], while
van Hooft et al, using an apparently similar protocol found
opposite results in a Dutch sample [44]. The only difference
between the two studies was that in the first case the patients were
supine, while in the latter they were sitting. It is difficult find an
explanation for the different observations. One possibility is the
different ethnic origin of the two samples, and another possibility
is the degree of stress in the experimental procedure. For
example, black normotensive offspring of hypertensive parents do
not change their blood pressure after psychological stress, while at
least one third of whites do [2, 45]. Moreover, at least a proportion
of normotensive offspring of hypertensive patients seem to have
exaggerated renal vascular responsivity to several provocative
maneuvers [46, 47]. Probably the best evidence for experimental
procedures influencing results is provided by Grim et al, who
studied the renal response to a sodium load in normotensive and
first-degree relatives of hypertensive subjects and found that the
latter group had a blunted natriuretic response to a saline load
only when it was measured in the standing position [48]. The
opposite tends to occur in the supine position, indicating that the
renal response to change in posture is different between subjects
with and without genetic predisposition to hypertension [48].
Biochemical-molecular mechanisms
Once it has been demonstrated that a renal abnormality is
responsible for a substantial proportion of hypertension, we have
to look for the underlying molecular-biochemical cause.
Higher rate of Na transport across the tubular cells of MHS rats
detected in the isolated kidney perfused in vitro were confirmed
when isolated renal tubules [49, 50] or luminal membranes were
studied [51—53]. Na transport is faster in almost all transport
systems studied; Na/H countertransport in brush border vesicles
[52], the Na-K cotransport in luminal membrane of the thick
ascending limb [51] and the Na,K-ATPase of the proximal and
ascending limb portions of the tubuli [50] translocate Na at higher
rate in MHS preparations than in MNS preparations. Such a
widespread alteration could not be due to a mutation in a transport
system protein, but in a mutation in a protein that controls these
systems. This observation, taken together with a difference in cell
volume and Na content between MHS and MNS [54, 55], and with
the disappearance of the transmembrane ion transport differences
between MHS and MNS after removal of the cytoskeleton in
inside-out vescicles [561, led to the hypothesis a cytoskeletal
protein is involved. In fact, only a genetically determined consti-
tutive cellular mechanism controlling different cell functions could
account for a large variety of cellular differences between MHS
and MNS, which were genetically associated with hypertension (as
assessed by genetic crosses) and were present in stem cells (as
assessed by bone marrow transplantation) [54]. Cross immuniza-
tions between MHS and MNS with cytoskeletal extracts of the
other strain were then performed, and yielded to the production
of antibodies against a protein subsequently identified as adducin
[57], a 200 kDa membrane skeletal protein consisting of an a-13
heterodimer with subunits of 103 kDa (a) and 97 kDa (13).
Adducin is involved in the control of many cellular functions. It
promotes binding between spectrin and actin in a calmodulin-
dependent way [58] and may play a role in regulating the rate of
ion transport across the cell membrane.
DNA polymorphism
The a and /3 adducin subunits are coded by two genes mapping
in separate chromosomes. Compared with MNS, MHS are char-
acterized by a substitution Tyr (Y) for Phe (F) on the gene of the
a subunit and a substitution Arg (R) for Gln (Q) on the gene of
the /3 subunit. However, the latter is still in segregation despite
inbreeding in MNS. An F2 population consisting of offspring of Fl
animals was obtained by crossing MHS with MNS. The blood
pressure levels in all adult individuals of the F2 generation were
measured. Analysis of the F2 generation demonstrated that Y
alleles segregated with a significant increase in blood pressure.
Moreover, the presence of R alleles on the f3 subunit increased
the difference between homozygous Y/Y and F/F a-adducin
genotypes, whereas the Q allele of /3-adducin abolished this
difference. The interactions between the two subunits suggest that
adducin plays a role in blood pressure control, with up to 50% of
the total blood pressure difference between the two parental
strains attributable to the mutation (Fig. 1) [59]. It was already
known that hypertension in MHS is determined by very few major
genes [601.
Unfortunately, studies of F2 generations cannot unequivocally
indicate the gene responsible for the phenotype. All genes map-
ping on a DNA segment of about 3 to 5 CM on either side of the
tested locus (polymorphic gene or DNA marker, in our case base
substitution in adducin coding region) may be responsible for the
phenotype under investigation (in our case the increase of blood
pressure). A strong argument in favor of adducin as the determi-
nant of hypertension is the particular assembly of a and /3 subunits
as a dimer, since a and /3 subunits are coded by genes mapping on
different chromosomes. It is then very unlikely that two different
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F2 population from MHS x MNS hybrids
(N=259)
MHS
MNS
genes, one mapping close to a-adducin and the other mapping
close to -adducin, display the same kind of epistatic interaction
(though this possibility cannot be ruled out). There are, however,
two additional arguments in favor of adducin: (1) adducin has
been identified following a reasonable biochemical-physiological
link (see above) and (2) heterozigosity for /3-adducin persists in
MNS in spite of more than 20 years of selective breeding. Such
hcterozigosity is segregating with significantly lower blood pres-
sure in a strain as the MNS that is selected for low blood pressure
[91. This polymorphism was also confirmed by selecting two
coisogenic MNS substrains (0/0 and RIR) and subsequently
obtaining their Fl hybrids (Q/R). This last substrain has signifi-
cantly lower blood pressure than the two parental strains [59],
In the attempt to verify if a-adducin could also be associated
with hypertension in humans, an association study was performed.
Four polymorphic multiallelic markers, located at different dis-
tances from the a-adducin locus, were studied on the assumption
that a-adducin possible mutations are in linkage disequilibrium
Fig. 1. Systolic blood pressure according to
adducin genolype. A. Only a-adducin genotypes
are considered irrespective of 13-adducin
genotype. Symbols are: (LII) n-adducin genotype
F/F; () a-adducin genotype F/Y; (U) a-
adducin genotype Y/Y. < 0.05 (one-way
ANOVA with Student-Newman-Keuels a
posteriori multiple comparison test). B. The
genotypes for a- and /3-adducin are considered
simultaneously. *p < 0.05; ** < 0.01 (one-way
ANOVA with Student-Newman-Kcuelsa
posteriori multiple comparison test),
significantly different from F/F a-adducin
genotype. One-way ANOVA was performed
separately for each /3-adducin ganotype. Mean
systolic blood pressure (horizontal solid lines)
SEM (shaded horizontal areas) for 10 rats of
each parental strain are also included for
appropriate comparison. Bottom panel is
reproduced from [58] with permission.
with the markers located in close proximity to the a-adducin locus.
The study on 190 hypertensive and 126 normotensive subjects
showed that the marker located in the closest proximity to the
a-adducin locus (20 Kb) was highly significantly associated with
hypertension [61]. The statistical association with the other DNA
markers (that is, the x2 value) decreased with increasing distance
from the a-adducin locus (Fig. 2). The way to unequivocally prove
the role of adducin in the pathogenesis of hypertension is to
reproduce the pathway from adducin mutations through biochem-
ical-physiological alteration to hypertension. Preliminary data
from two different experiments are available. Pure a-adducin
prepared from MHS cell membranes in vitro produces a higher
degree of actin polymerization and bundling than that from MNS.
Such a phenomenon may affect cell Na transport. A stabilized line
of rat kidney tubular cells (NRK52-E) has been transfected with
either MHS or MNS cs-adducin eDNA. Clones expressing MHS
adducin had a significantly greater Na pump activity at V,, and
a larger number of Na pump units expressed on the cell surface
—1.0 Mb-
[0431251 16;tsgiI'r I1I____ ____ S22&E5 6-
Chromosome 4
I -iii
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GuIDI E, MEMGHENI D, MILANI S, MONTAGNINO G, PALAZZI P, BlANCH!
G: Hypertension may be transplanted with the kidney in humans. A long
term historical prospective follow-up of recipients with kidneys coming
from donors with or without hypertension in their families. J Am Soc
Nephrol (in press).
Fig. 2. values for the analysis of the allelic distribution between hyperten-
sives and normotensives. 2 valuescan be directly compared since they have
all 1 degree of freedom. The horizontal line indicates the critical signifi-
cance level. The chromosomal positions of the studied markers are
indicated, together with the genes already described in the same region of
chromosome 4: (1.) Huntington disease related gene; (2.) G protein-
coupled receptor kinase; (3.) u-adducin; (4.) fibroblast growth factor
receptor 3; (5.) a-L-iduronidase; (6.) cGMP phosphodiesterase 13. Repro-
duced from [60] with permission.
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